582 related articles for article (PubMed ID: 25842581)
1. Prevalence of albicans and non-albicans candiduria in a Malaysian medical centre.
Ding CH; Wahab AA; Muttaqillah NA; Tzar MN
J Pak Med Assoc; 2014 Dec; 64(12):1375-9. PubMed ID: 25842581
[TBL] [Abstract][Full Text] [Related]
2. Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria.
Ozhak-Baysan B; Ogunc D; Colak D; Ongut G; Donmez L; Vural T; Gunseren F
Med Mycol; 2012 Jul; 50(5):529-32. PubMed ID: 21988703
[TBL] [Abstract][Full Text] [Related]
3. [Molecular epidemiology and antifungal susceptibility of Candida species isolated from urine samples of patients in intensive care unit].
Yüksekkaya S; Fındık D; Arslan U
Mikrobiyol Bul; 2011 Jan; 45(1):137-49. PubMed ID: 21341168
[TBL] [Abstract][Full Text] [Related]
4. Antifungal susceptibilities of Candida species isolated from urine culture.
Toka Özer T; Durmaz S; Yula E
J Infect Chemother; 2016 Sep; 22(9):629-32. PubMed ID: 27452427
[TBL] [Abstract][Full Text] [Related]
5. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
6. Yeasts isolated from nosocomial urinary infections: antifungal susceptibility and biofilm production.
de Freitas AR; Baeza LC; Faria MG; Dota KF; Godoy Martínez P; Svidzinski TI
Rev Iberoam Micol; 2014; 31(2):104-8. PubMed ID: 23810785
[TBL] [Abstract][Full Text] [Related]
7. Candida growth in urine cultures: a contemporary analysis of species and antifungal susceptibility profiles.
Toner L; Papa N; Aliyu SH; Dev H; Lawrentschuk N; Al-Hayek S
QJM; 2016 May; 109(5):325-9. PubMed ID: 26537955
[TBL] [Abstract][Full Text] [Related]
8. Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis.
Yang YL; Ho YA; Cheng HH; Ho M; Lo HJ
Infect Control Hosp Epidemiol; 2004 Jan; 25(1):60-4. PubMed ID: 14756222
[TBL] [Abstract][Full Text] [Related]
9. Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study.
Schmalreck AF; Willinger B; Haase G; Blum G; Lass-Flörl C; Fegeler W; Becker K;
Mycoses; 2012 May; 55(3):e124-37. PubMed ID: 22233267
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and antifungal susceptibility of Candida species in a tertiary care hospital in Islamabad, Pakistan.
Tasneem U; Siddiqui MT; Faryal R; Shah AA
J Pak Med Assoc; 2017 Jul; 67(7):986-991. PubMed ID: 28770873
[TBL] [Abstract][Full Text] [Related]
11. [In vitro activity of amphotericin B, fluconazole and itraconazole against Candida glabrata strains isolated from clinical samples].
Hüseyin A; Sancak B; Arikan S
Mikrobiyol Bul; 2007 Apr; 41(2):235-44. PubMed ID: 17682710
[TBL] [Abstract][Full Text] [Related]
12. Identification and antifungal susceptibility of Candida species isolated from the urine of patients in a university hospital in Brazil.
Lima GME; Nunes MO; Chang MR; Tsujisaki RAS; Nunes JO; Taira CL; Thomaz DY; Negro GMBD; Mendes RP; Paniago AMM
Rev Inst Med Trop Sao Paulo; 2017 Dec; 59():e75. PubMed ID: 29267583
[TBL] [Abstract][Full Text] [Related]
13. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
Panizo MM; Reviákina V; Dolande M; Selgrad S
Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
[TBL] [Abstract][Full Text] [Related]
14. Species distribution and fluconazole susceptibility of Candida clinical isolates in a medical center in 2002.
Wang JL; Chang SC; Hsueh PR; Chen YC
J Microbiol Immunol Infect; 2004 Aug; 37(4):236-41. PubMed ID: 15340652
[TBL] [Abstract][Full Text] [Related]
15. In vitro antifungal susceptibility testing of Candida blood isolates and evaluation of the E-test method.
Lu JJ; Lee SY; Chiueh TS
J Microbiol Immunol Infect; 2004 Dec; 37(6):335-42. PubMed ID: 15599465
[TBL] [Abstract][Full Text] [Related]
16. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
[TBL] [Abstract][Full Text] [Related]
17. Fluconazole therapy for Candida albicans urinary tract infections in infants.
Triolo V; Gari-Toussaint M; Casagrande F; Garraffo R; Dageville C; Boutté P; Bérard E
Pediatr Nephrol; 2002 Jul; 17(7):550-3. PubMed ID: 12172774
[TBL] [Abstract][Full Text] [Related]
18. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
Altuncu E; Bilgen H; Cerikçioğlu N; Ilki A; Ulger N; Bakır M; Akman I; Ozek E
Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972
[TBL] [Abstract][Full Text] [Related]
19. [Antifungal susceptibility of Candida spp. isolates from blood cultures in a five-year period (1997-2001)].
Durán MT; Velasco D; Canle D; Moure R; Villanueva R
Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):488-92. PubMed ID: 14572381
[TBL] [Abstract][Full Text] [Related]
20. Species distribution, antifungal susceptibility and clonal relatedness of Candida isolates from patients in neonatal and pediatric intensive care units at a medical center in Turkey.
Kuzucu C; Durmaz R; Otlu B; Aktas E; Gulcan H; Cizmeci Z
New Microbiol; 2008 Jul; 31(3):401-8. PubMed ID: 18843896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
